Recent Finacing
Recent Raise
Ablatus Therapeutics develops Bimodal Electric Tissue Ablation (BETA) devices that combine AC and DC currents to reduce charring, expand ablation zones, and enable treatment of tumors previously considered untreatable.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Ablatus Therapeutics.
